Published in Journal of Urology, 2016. Authors: Costa D, Lotan Y, Rofsky NM, Roehrborn C, Liu A, Hornberger B, Xi Y, […]
Abstract Category: Peer-Reviewed
An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-preliminary experience
Published in Urologic Oncology, April 2017. Authors: Costa DN, Kay FU, Pedrosa I, Kolski L, Lotan Y, Roehrborn CG, Hornberger B, […]
Optimal sampling scheme in men with abnormal multiparametric MRI undergoing MRI-TRUS fusion prostate biopsy
Published in Urologic Oncology, January 2019. Authors: Freifeld Y, Xi Y, Passoni N, Woldu S, Hornberger B, Goldberg K, Bagrodia A, […]
Molecular Subtyping of Clinically Localized Urothelial Carcinoma Reveals Lower Rates of Pathological Upstaging at Radical Cystectomy Among Luminal Tumors
Published in European Urology, August 2019. Authors: Lotan Y, Boorjian SA, Zhang J, Bivalacqua TJ, Porten SP, Wheeler T, Lerner SP, […]
Utility of PTEN and ERG Immunostaining for Distinguishing High-grade PIN from Intraductal Carcinoma of the Prostate on Needle Biopsy
Published in The American Journal of Surgical Pathology, 2015. Authors: Morais CL, Han JS, Gordetsky J, Nagar MS, Anderson AE, Lee […]
Heterogeneity of PTEN and ERG Expression in Prostate Cancer on Core Needle Biopsies: Implications for Cancer Risk Stratification and Biomarker Sampling
Published in Human Pathology, 2015. Authors: Shah RB, Bentley J, Jeffery Z and DeMarzo AM. For a copy, please contact Inform Diagnostics.
Signaling mechanisms coupled to CXCL12/CXCR4-mediated cellular proliferation are PTEN-dependent
Published in The American Journal of Clinical and Experimental Urology, 2015. Authors: Begley LA, Kasina S, Shah RB, and Macoska JA. […]
ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia
Published in Urologic Oncology, 2015. Authors: Shah RB, Li J, Dhanani N, and Mendrinos S. For a copy, please contact Inform Diagnostics.
Diagnosis of Gleason pattern 5 prostate adenocarcinoma on core needle biopsy: an interobserver reproducibility study among urologic pathologists
Published in The American Journal of Surgical Pathology, September 2015. Authors: Shah RB, Li J, Cheng L, Egevad L, Deng FM, Fine […]
Diagnosis of “poorly formed glands” Gleason pattern 4 prostatic adenocarcinoma on needle biopsy: an interobserver reproducibility study among urologic pathologists with recommendations
Published in The American Journal of Surgical Pathology, October 2015. Authors: Zhou M, Li J, Cheng L, Egevad L, Deng FM, Kunju […]
Improvement in inter-observer reproducibility in resolving an “Atypical glands suspicious for prostate cancer” diagnosis in prostate biopsies using a novel “Diseased focused diagnostic review” quality process
Published in Human Pathology, 2016. Authors: Shah RB, Leandro G, Romerocases G, Bentley J, Yoon J, Mendrinos S, Tadros Y, Tian W, and […]
Atypical intraductal proliferation and intraductal carcinoma of the prostate on core needle biopsy: a comparative clinicopathological and molecular study with a proposal to expand morphological spectrum of intraductal carcinoma
Published in Histopathology, November 2017. Authors: Shah RB, Yoon J, Liu G, and Tian W. For a copy, please contact Inform Diagnostics.
GATA3 expression in benign prostate glands with radiation atypia: a diagnostic pitfall
Published in Histopathology, July 2017. Authors: Tian W, Dorn D, Wei S, Sanders RD, Matoso A, Shah RB, and Gordetsky […]
PTEN loss in prostatic adenocarcinoma correlates with specific adverse histologic features (intraductal carcinoma, cribriform Gleason pattern 4 and stromogenic carcinoma
Published in Prostate, August 2019. Authors: Shah RB, Shore KT, and Tian W. For a copy, please contact Inform Diagnostics.
Urine cytology diagnostic patterns before and after implementing the paris system for reporting urine cytology: a large single institutional study of over 27,000 cases
In prep. Authors: Tian W, Shore KT, and Shah RB. For a copy, please contact Inform Diagnostics.
